Skip to content
Biodatica
Start free

Investigator

Ahmed Nabil Zobi

SYNTR HEALTH TECHNOLOGIES, LLC · funded by NCATS, NCI

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.8M

Summed across those awards.

First award
Aug 15, 2025

Latest Sep 25, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R44

    Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue Microsizing

    $1.1M

    Sep 25, 2025NCATSSYNTR HEALTH TECHNOLOGIES, LLCNIH RePORTER · 11253865 (opens the source filing in a new tab)

  2. R43

    Accelerating Bioengineering Approaches for Increasing Access to New Solutions Targeting Breast Cancer Reconstructive Surgery

    $357k

    Sep 2, 2025NCISYNTR HEALTH TECHNOLOGIES, LLCNIH RePORTER · 11253864 (opens the source filing in a new tab)

  3. R43

    Rapid and Automated Dissociation of Tumor Tissue for Single Cell Diagnostics

    $407k

    Aug 15, 2025NCATSSYNTR HEALTH TECHNOLOGIES, LLCNIH RePORTER · 11070092 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources